Entera Bio Ltd (ENTX)
2.39
+0.23
(+10.65%)
USD |
NASDAQ |
May 06, 16:00
2.38
-0.01
(-0.42%)
After-Hours: 20:00
Entera Bio Price: 2.39 for May 6, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 06, 2024 | 2.41 | 2.50 | 2.17 | 2.39 | 229411.0 |
May 03, 2024 | 2.08 | 2.20 | 2.02 | 2.16 | 236042.0 |
May 02, 2024 | 2.05 | 2.12 | 1.93 | 2.09 | 277338.0 |
May 01, 2024 | 1.99 | 2.04 | 1.90 | 2.00 | 70670.00 |
Apr 30, 2024 | 1.99 | 2.02 | 1.844 | 1.96 | 196522.0 |
Apr 29, 2024 | 1.99 | 2.14 | 1.973 | 2.01 | 377977.0 |
Apr 26, 2024 | 1.97 | 2.030 | 1.91 | 1.98 | 118877.0 |
Apr 25, 2024 | 2.03 | 2.07 | 1.93 | 2.00 | 117782.0 |
Apr 24, 2024 | 2.20 | 2.258 | 2.01 | 2.07 | 163385.0 |
Apr 23, 2024 | 2.05 | 2.24 | 1.97 | 2.22 | 115725.0 |
Apr 22, 2024 | 1.85 | 2.14 | 1.810 | 2.05 | 172695.0 |
Apr 19, 2024 | 2.24 | 2.29 | 1.95 | 1.99 | 300780.0 |
Apr 18, 2024 | 2.19 | 2.32 | 2.18 | 2.24 | 167401.0 |
Apr 17, 2024 | 2.20 | 2.269 | 2.06 | 2.22 | 209349.0 |
Apr 16, 2024 | 2.40 | 2.486 | 2.06 | 2.29 | 552937.0 |
Apr 15, 2024 | 3.00 | 3.22 | 2.380 | 2.52 | 686894.0 |
Apr 12, 2024 | 2.75 | 3.35 | 2.65 | 2.98 | 1.940M |
Apr 11, 2024 | 2.26 | 2.70 | 2.25 | 2.66 | 691314.0 |
Apr 10, 2024 | 2.23 | 2.69 | 2.15 | 2.23 | 841362.0 |
Apr 09, 2024 | 1.97 | 2.32 | 1.95 | 2.25 | 366416.0 |
Apr 08, 2024 | 2.00 | 2.050 | 1.86 | 1.95 | 361068.0 |
Apr 05, 2024 | 1.97 | 2.00 | 1.903 | 1.985 | 463146.0 |
Apr 04, 2024 | 1.79 | 1.990 | 1.740 | 1.90 | 246454.0 |
Apr 03, 2024 | 1.86 | 1.915 | 1.65 | 1.73 | 198203.0 |
Apr 02, 2024 | 1.90 | 1.97 | 1.69 | 1.86 | 320071.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.50
Minimum
Nov 11 2022
6.90
Maximum
Mar 12 2021
2.095
Average
1.89
Median
Feb 10 2021
Price Benchmarks
BiomX Inc | 0.408 |
Compugen Ltd | 2.15 |
Pluri Inc | 5.60 |
BioLine Rx Ltd | 0.7039 |
Can Fite Biofarma Ltd | 2.11 |
Price Related Metrics
PS Ratio | 515.21 |
Price to Book Value | 8.131 |
Earnings Yield | -13.03% |
Market Cap | 84.80M |